Small-molecule-based protein-labeling technology in live cell studies: probe-design concepts and applications
It may aid in healing of stomach ulcers, reducing gut inflammation, help with leaky gut syndrome and improving overall digestive health
Orthostatic challenge causes distinctive symptomatic, hemodynamic and cognitive responses in long COVID and myalgic encephalomyelitis/chronic fatigue syndrome
(Medicare Policy Initiative) FDA approvals matter: When a GLP-1 drug gains an FDA label for something like reducing heart attack risk (beyond weight loss), that opens up possible Medicare Part D coverage for that use
Yes and the combination is often more effective than either alone
Morris, MD, MBA shared thisThis week, Tennr CMO William H